Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene
Crissy Dudgeon(Rutgers, The State University of New Jersey), Dmitry V. Bulavin(Centre National de la Recherche Scientifique), David P. Lane(Science for Life Laboratory), Ettore Appella(National Institutes of Health), Calvina Kek(Institute of Molecular and Cell Biology), Alexandra Diot(University of Dundee), Oleg N. Demidov(Université de Bourgogne), Jean‐Christophe Bourdon(University of Dundee), Albert J. Fornace(Georgetown University), Shinichi Saito(Pharmaceutical Biotechnology (Czechia)), Kenneth Fernandes(University of Dundee)
Cited by 27
Related Papers
DNA damage activates p53 through a phosphorylation–acetylation cascade
|Genes & Development|1998|1.2k
p53 isoforms can regulate p53 transcriptional activity
|Genes & Development|2005|802
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway
|Nature Genetics|2004|407
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
|OncoTargets and Therapy|2013|376
Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways
|Molecular Cell|2006|347